THE CONTROL OF THE ANTIBODY ISOTYPE RESPONSE TO RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS GP120 ANTIGEN BY ADJUVANTS

被引:83
|
作者
BOMFORD, R
STAPLETON, M
WINSOR, S
MCKNIGHT, A
ANDRONOVA, T
机构
[1] WELLCOME RES LABS, BECKENHAM BR3 3BS, KENT, ENGLAND
[2] INST CANC RES, LONDON SW3 6JB, ENGLAND
[3] MM SHEMYAKIN BIOORGAN CHEM INST, MOSCOW 117871, USSR
关键词
D O I
10.1089/aid.1992.8.1765
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Both saponin and muramyl dipeptide (MDP) formulated with a squalane-in-water emulsion of large particle size prepared with a vortex mixer were superior to Al(OH)3 as adjuvants for HIV gp120 in mice. All the adjuvants induced IgG1 antibody, but saponin elicited the highest titers of IgG2a. The secretion of interleukin-5 (IL-5) and interferongamma (IFNgamma) by lymph node cells cultured in vitro with gp120 was studied. All the cultures secreted IL-5, but only those from saponin-immunized mice produced IFNgamma, suggesting that saponin is capable of activating both the Th1 and TH2 T-cell subsets. The titers of neutralizing antibodies were low with both MDP and saponin, and they occurred in mice which were also positive for antibodies against a V3 loop peptide. Glucosaminylmuramyl dipeptide (GMDP) which is less pyrogenic than MDP and a nonpyrogenic analog GMDPA, displayed equivalent adjuvant activity to MDP. The level and isotype composition of antibodies induced by GMDP in combination with squalane emulsions depended on the dimension of the emulsion particles. With a large (2500 nm) particle size the response was confined to IgG1 in Balb/c mice, but when this was reduced to 150 nm by sonication the antibody response was increased and relatively high levels of IgG2a appeared in some mice.
引用
收藏
页码:1765 / 1771
页数:7
相关论文
共 50 条
  • [1] HUMAN-IMMUNODEFICIENCY-VIRUS GP120 GLYCOPROTEIN DETECTED BY A MONOCLONAL-ANTIBODY TO A SYNTHETIC PEPTIDE
    CHANH, TC
    KENNEDY, RC
    ALDERETE, BE
    KANDA, P
    EICHBERG, JW
    DREESMAN, GR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (11) : 1465 - 1468
  • [2] INHIBITION OF THE OFFSPRING ANTI-RECOMBINANT GP120 ANTIBODY-RESPONSE TO A HUMAN-IMMUNODEFICIENCY-VIRUS VACCINE BY MATERNAL IMMUNIZATION IN A MURINE MODEL
    JELONEK, MT
    MASKREY, JL
    STEIMER, KS
    POTTS, BJ
    HIGGINS, KW
    KELLER, MA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (02): : 539 - 542
  • [3] SELECTIVE EFFECTS OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) GP120 ON INVERTEBRATE NEURONS
    STEFANO, GB
    SAWADA, M
    SMITH, EM
    HUGHES, TK
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 1993, 13 (06) : 569 - 577
  • [4] CHARACTERIZATION OF THE SECRETED, NATIVE GP120 AND GP160 OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    KALYANARAMAN, VS
    RODRIGUEZ, V
    VERONESE, F
    RAHMAN, R
    LUSSO, P
    DEVICO, AL
    COPELAND, T
    OROSZLAN, S
    GALLO, RC
    SARNGADHARAN, MG
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (03) : 371 - 380
  • [5] A HEPARIN WHICH BINDS TO THE ENVELOPE GLYCOPROTEIN GP120 INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION
    CARDIN, AD
    TAYLOR, DL
    KRSTENANSKY, JL
    TYMS, AS
    JACKSON, RL
    [J]. TRANSACTIONS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, VOL 102, 1989, 102 : 101 - 109
  • [6] OLIGOMERIC ORGANIZATION OF GP120 ON INFECTIOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES
    WEISS, CD
    LEVY, JA
    WHITE, JM
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (11) : 5674 - 5677
  • [7] SEROLOGICAL RESPONSES IN CHIMPANZEES INOCULATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS GLYCOPROTEIN (GP120) SUBUNIT VACCINE
    ARTHUR, LO
    PYLE, SW
    NARA, PL
    BESS, JW
    GONDA, MA
    KELLIHER, JC
    GILDEN, RV
    ROBEY, WG
    BOLOGNESI, DP
    GALLO, RC
    FISCHINGER, PJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) : 8583 - 8587
  • [8] DIFFERENT PROLIFERATIVE RESPONSE OF HUMAN AND CHIMPANZEE LYMPHOCYTES AFTER CONTACT WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120
    DIRIENZO, AM
    FURLINI, G
    OLIVIER, R
    FERRIS, S
    HEENEY, J
    MONTAGNIER, L
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (01) : 34 - 40
  • [9] Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins
    Liao, HX
    Alam, SM
    Mascola, JR
    Robinson, J
    Ma, BJ
    Montefiori, DC
    Rhein, M
    Sutherland, LL
    Scearce, R
    Haynes, BF
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (10) : 5270 - 5278
  • [10] Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines
    Gorse, GJ
    Patel, GB
    Newman, FK
    Belshe, RB
    Berman, PW
    Gregory, TJ
    Matthews, TJ
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (04) : 378 - 386